Our therapy also appears to be highly effective for eradicating other types of cancers which express varying levels of FRα, including breast and pancreatic cancers expressing WT and/or mutant BRCA1 and/or BRCA2 (Schutsky and Powell, 2014, unpublished observations). This evidence concerns the gene FOLR1 and cancer.